California Public Employees Retirement System
BCLI

California Public Employees Retirement System’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

California Public Employees Retirement System’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,873
Closed -$223K – 1704
2021
Q1 		$223K Hold
3,873
– – ﹤0.01% 3330
2020
Q4 		$263K Sell
3,873
-80
-2% -$10.9K ﹤0.01% 3250
2020
Q3 		$1M Buy
3,953
+353
+10% +$72.3K ﹤0.01% 2286
2020
Q2 		$605K Buy
+3,600
New +$388K ﹤0.01% 2570

Other funds holding BCLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AHB
Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

California Public Employees Retirement System's BCLI Position: Q2 2021 in Review

California Public Employees Retirement System sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q2 2021, closing a stake of 3,873 shares — an estimated $223K sold.

California Public Employees Retirement System first reported a position in BCLI in Q2 2020 and held it in 4 quarters. The position peaked at $1M in Q3 2020. 57 funds tracked by Wall St. Rank hold BCLI as of Q2 2021.

  • California Public Employees Retirement System reported no remaining BRAINSTORM CELL THERAPUTC position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 3,873 BRAINSTORM CELL THERAPUTC shares in Q2 2021, an estimated $223K.
  • California Public Employees Retirement System first reported a position in BRAINSTORM CELL THERAPUTC in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's BRAINSTORM CELL THERAPUTC position peaked at $1M in Q3 2020.
  • 57 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.